Literature DB >> 18056223

Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects.

Christina Dalman1, Peter Allebeck, David Gunnell, Glyn Harrison, Krister Kristensson, Glyn Lewis, Sofia Lofving, Finn Rasmussen, Susanne Wicks, Håkan Karlsson.   

Abstract

OBJECTIVE: Infections during early life have been suggested to play a role in the etiology of schizophrenia. Most studies have focused on fetal life; few have explored risk associated with infection during childhood. The results of these have been inconsistent. The present study aims to investigate whether there is an increased risk of schizophrenia and other nonaffective psychoses associated with viral or bacterial CNS infections during childhood and, if so, which specific agents are involved.
METHOD: A national cohort consisting of 1.2 million children born between 1973 and 1985 was followed up by using Swedish national registers to retrieve data on hospital admissions for CNS infections at 0-12 years of age (bacterial: N=2,435, viral: N=6,550) as well as admissions for nonaffective psychotic illnesses from the 14th birthday (N=2,269).
RESULTS: There was a slightly increased risk of nonaffective psychotic illness associated with viral CNS infections, as well as schizophrenia. There was no evidence of increased risk in relation to bacterial infections. When divided into specific agents, exposures to mumps virus or cytomegalovirus were associated with subsequent psychoses.
CONCLUSIONS: Serious viral CNS infections during childhood appear to be associated with the later development of schizophrenia and nonaffective psychoses. The association with specific viruses suggests that the risk is related to infectious agents with a propensity to invade the brain parenchyma.

Entities:  

Mesh:

Year:  2007        PMID: 18056223     DOI: 10.1176/appi.ajp.2007.07050740

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  65 in total

Review 1.  Potential microbial origins of schizophrenia and their treatments.

Authors:  S Hossein Fatemi
Journal:  Drugs Today (Barc)       Date:  2009-04       Impact factor: 2.245

Review 2.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

3.  Association between prenatal exposure to bacterial infection and risk of schizophrenia.

Authors:  Holger J Sørensen; Erik L Mortensen; June M Reinisch; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2008-10-01       Impact factor: 9.306

4.  Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.

Authors:  Brian H Shirts; Konasale M Prasad; Michael F Pogue-Geile; Faith Dickerson; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Schizophr Res       Date:  2008-09-17       Impact factor: 4.939

Review 5.  Fetal origins of adult disease.

Authors:  Kara Calkins; Sherin U Devaskar
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2011-07

6.  Integrative Analysis of Disease Signatures Shows Inflammation Disrupts Juvenile Experience-Dependent Cortical Plasticity.

Authors:  Milo R Smith; Poromendro Burman; Masato Sadahiro; Brian A Kidd; Joel T Dudley; Hirofumi Morishita
Journal:  eNeuro       Date:  2017-01-18

7.  Sibling characteristics and early onset psychoses among the young adolescent patient population.

Authors:  Leena Stenudd; Helinä Hakko; Pirkko Räsänen; Kaisa Riala
Journal:  Child Psychiatry Hum Dev       Date:  2014

8.  Immune System and Schizophrenia.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Curr Immunol Rev       Date:  2010-08

9.  Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism.

Authors:  Christine Winter; Teri J Reutiman; Timothy D Folsom; Reinhard Sohr; Rainer J Wolf; Georg Juckel; S Hossein Fatemi
Journal:  Eur Neuropsychopharmacol       Date:  2008-08-06       Impact factor: 4.600

10.  Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms.

Authors:  Emily G Severance; Faith B Dickerson; Raphael P Viscidi; Ioannis Bossis; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.